Volume 28, Issue 2 - Generics and biosimilars

Medical Devices

Author: Beatrix Döerr

Abstract

Download the full article

References

1. Implant files: Health authorities across the globe have failed to protect millions of patients from poorly tested implants, the first-ever global examination of the medical device industry reveals. [cited 2018 Dec 08]. Available at: Available from: https://www.icij.org/ investigations/implant-files/.
2. Doerr B. The next medical device scandal: medical device files – my personal view (part 1). Med Writ. 2019;28:86–9.
3. Was Sie über die Implant Files wissen müssen [cited 2018 Dec 08]. Available at: Available from: https://www.sueddeutsche.de/politik/ implant-files-fakten-ueberblick-1.4225363.
4. ISO14155:2011: Clinical investigation of medical devices for human subjects – Good Clinical Practice [cited 2019 Feb 22]. Available at Available from: https://www.iso.org/standard/ 45557.html.
5. Physician Payment Sunshine Act. [cited 2018 Dec 30]. Available at Available from: https://en.wikipedia.org/wiki/ PhysicianvPayments_Sunshine_Act.
6. International Physician Payments Sunshine: EFPIA Code on Transfers of Value and Inconsistencies Within European Member Associations. [cited on 2018 Dec 30]. Available at Available from: https://bit.ly/2R1Qekf.
7. “Sunshine Act” in Europe: strengthening of transparency obligations for the pharmaceutical and medical device sectors. [cited on 2019 Mar 04]. Available at Available from: http://www.mercure-avocats.com/en/ news/news-detail/sunshine-act-in-europestrengthening- of-transparency-obligationsfor- the-pharmaceutical-and-medical-device -sectors.
8. The Sun Shines on Europe. Transparency of financial relationships in the healthcare sector. [cited 2019 Mar 04]. Available at Available from: http://haiweb.org/wp-content/uploads/ 2017/03/Sunshine-Act.pdf.
9. Sunshine Transparency Laws, Regulations and Codes Across Europe [cited on 2019 Mar 04]. Available at Available from: https://mhesme. org/wp-content/uploads/2017/09/ Mapping-of-Sunshine-Laws-in-Europe.pdf
10. Didier R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, et al. Five-year clinical outcome and valve durability after transcatheter aortic valve replacement in high-risk patients. Circulation. 2018;138:2597–607.
11. Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes with transcatheter mitral valve repair in the United States: An STS/ACC TVT Registry report. J Am Coll Cardiol. 2017;70:2315–27.
12. Lange R, Beckmann A, Neumann T, et al. Quality of life after transcatheter aortic valve replacement: prospective data from GARY (German Aortic Valve Registry). JACC Cardiovasc Interv. 2016;9:2541–54.
13. Sarno G, Lagerqvist B, Olivecrona G, et al. Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Catheter Cardiovasc Interv. 2017;90:881–7.
14. MDR2017/745. [cited on 2019 Jan 01]. Available at Available from: https://ces.to/mmJHhd.
15. Zeller T, Krankenberg H, Erglis A, et al. A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) – one-year results of a pre-maturely terminated study. Trials. 2017;18:380. doi: 10.1186/s1306.
16. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
17. Medical devices: European Commission calls for immediate actions – tighten controls, increase surveillance, restore confidence. [cited on 2019 Jan 10]. Available at: Available from: http://europa.eu/rapid/pressrelease_ IP-12-119_en.htm
18. New steps to facilitate beneficial medical device innovation [cited 2019 Jan 11]. Available at: Available from: https://www.fda.gov/ NewsEvents/Newsroom/FDAVoices/ ucm612001.htm.